| TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells T Li, J Fan, B Wang, N Traugh, Q Chen, JS Liu, B Li, XS Liu Cancer research 77 (21), e108-e110, 2017 | 4658 | 2017 |
| Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ... Nature medicine 24 (10), 1550-1558, 2018 | 3378 | 2018 |
| Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute B Wang, M Wang, W Zhang, T Xiao, CH Chen, A Wu, F Wu, N Traugh, ... Nature protocols 14 (3), 756-780, 2019 | 307 | 2019 |
| Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade SS Gu, W Zhang, X Wang, P Jiang, N Traugh, Z Li, C Meyer, B Stewig, ... Cancer Discovery 11 (6), 1524-1541, 2021 | 129 | 2021 |
| In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target X Wang, C Tokheim, SS Gu, B Wang, Q Tang, Y Li, N Traugh, Z Zeng, ... Cell 184 (21), 5357-5374. e22, 2021 | 108 | 2021 |
| Clonal tracing reveals diverse patterns of response to immune checkpoint blockade SS Gu, X Wang, X Hu, P Jiang, Z Li, N Traugh, X Bu, Q Tang, C Wang, ... Genome biology 21, 1-28, 2020 | 18 | 2020 |
| CRISPR screens identify essential cell growth mediators in BRAF inhibitor-resistant melanoma Z Li, B Wang, S Gu, P Jiang, A Sahu, CH Chen, T Han, S Shi, X Wang, ... Genomics, Proteomics and Bioinformatics 18 (1), 26-40, 2020 | 18 | 2020 |
| Advancements in Human Breast Organoid Culture: Modeling Complex Tissue Structures and Developmental Insights G Rauner, N Traugh, C Trepicchio, ME Parrish, K Mushayandebvu, ... bioRxiv, 2023.10. 02.560364, 2023 | 1 | 2023 |
| DDR1 regulates RUNX1-CBFβ to control breast stem cell differentiation C Trepicchio, G Rauner, N Traugh, M Parrish, Y Mal, DEC Fein, ... bioRxiv, 2024.02. 21.581255, 2024 | | 2024 |
| Selective inhibition of fibroblast-specific Domain Discoidin Receptor 1 (DDR1) reduces collagen deposition and modulates fibroblast-specific cytokine release within the breast … DEC Fein, N Traugh, G Rauner, Y Mal, C Trepicchio, C Kuperwasser bioRxiv, 2023.08. 11.552937, 2023 | | 2023 |
| Selective inhibition of fibroblast-specific domain discoidin receptor 1 (DDR1) results in reduced collagen deposition and immunomodulatory cytokine release: A potential target … DEC Fein, N Traugh, G Rauner, Y Mal, C Trepicchio, C Kuperwasser CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Abstract P5-06-07: Selective inhibition of fibroblast-specific domain discoidin receptor 1 (DDR1) results in reduced collagen deposition and immunomodulatory cytokine release … DEC Fein, N Traugh, G Rauner, Y Mal, C Trepicchio, C Kuperwasser Cancer Research 82 (4_Supplement), P5-06-07-P5-06-07, 2022 | | 2022 |
| Abstract P108: In vivo CRISPR screens identify E3 ligase COP1 as a modulator of macrophage infiltration and cancer immunotherapy target X Wang, C Tokheim, SS Gu, B Wang, Q Tang, Y Li, N Traugh, Z Zeng, ... Molecular Cancer Therapeutics 20 (12_Supplement), P108-P108, 2021 | | 2021 |
| 700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy S Gu, W Zhang, X Wang, P Jiang, N Traugh, Z Li, C Meyer, B Stewig, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant Melanoma LI Ziyi, W Binbin, GU Shengqing, P JIANG, S Avinash, C Chen-Hao, ... Genomics, Proteomics & Bioinformatics, 26-40, 2020 | | 2020 |
| Clonal tracing reveals different mechanisms of resistance to immune checkpoint blockade S Gu, X Hu, X Wang, P Jiang, Z Li, N Traugh, X Bu, X Xing, GJ Freeman, ... Cancer Research 79 (13_Supplement), 3779-3779, 2019 | | 2019 |
| Abstract A077: Microenvironmental factors shape resistance patterns to immune checkpoint blockade SS Gu, XS Hu, XS Wang, Z Li, N Traugh, X Bu, X Xing, G Freeman, ... Cancer Immunology Research 7 (2_Supplement), A077-A077, 2019 | | 2019 |
| Abstract B077: Signatures of T-cell dysfunction and exclusion predict cancer immunotherapy response P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ... Cancer Immunology Research 7 (2_Supplement), B077-B077, 2019 | | 2019 |
